Trade Metlife - MET CFD

Add to favourite

69.89

1.5%

0.12

Low: 69.43

High: 70.02

Market Trading Hours* (UTC) Opens on Friday at 13:30

Mon - Fri: 13:30 - 20:00

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.12

Long position overnight fee

-0.026179%

Short position overnight fee

0.003957%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

Stock exchange

United States of America

Commission on trade

*Information provided by Capital.com

MetLife Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	68.86
Open*	69.43
1-Year Change*	13.13%
Day's Range*	69.43 - 70.02
52 wk Range	48.95-73.28
Average Volume (10 days)	3.81M
Average Volume (3 months)	77.10M
Market Cap	50.13B
P/E Ratio	29.06
Shares Outstanding	740.19M
Revenue	64.19B
EPS	2.33
Dividend (Yield %)	3.07147
Beta	1.04
Next Earnings Date	Jan 31, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 18, 2024	69.89	0.94	1.36%	68.95	70.09	68.95
Apr 17, 2024	68.86	-0.14	-0.20%	69.00	69.62	68.51
Apr 16, 2024	68.85	-0.48	-0.69%	69.33	69.57	68.64
Apr 15, 2024	69.37	-1.42	-2.01%	70.79	71.55	69.18
Apr 12, 2024	70.08	-0.37	-0.53%	70.45	71.27	69.68
Apr 11, 2024	70.89	-0.41	-0.58%	71.30	71.45	70.17
Apr 10, 2024	71.81	-0.07	-0.10%	71.88	72.24	71.23
Apr 9, 2024	72.82	-0.46	-0.63%	73.28	74.11	72.19
Apr 8, 2024	73.72	0.28	0.38%	73.44	73.95	73.29
Apr 5, 2024	73.55	0.58	0.79%	72.97	73.75	72.74
Apr 4, 2024	73.08	-1.13	-1.52%	74.21	74.62	72.74
Apr 3, 2024	73.50	0.51	0.70%	72.99	73.97	72.99
Apr 2, 2024	73.17	0.05	0.07%	73.12	73.95	73.03
Apr 1, 2024	73.62	-0.01	-0.01%	73.63	74.08	73.09
Mar 28, 2024	74.05	0.10	0.14%	73.95	74.32	73.40
Mar 27, 2024	73.88	0.42	0.57%	73.46	73.91	72.93
Mar 26, 2024	73.00	0.61	0.84%	72.39	73.32	72.30
Mar 25, 2024	73.04	0.52	0.72%	72.52	73.41	72.52
Mar 22, 2024	72.55	-1.01	-1.37%	73.56	73.80	72.54
Mar 21, 2024	73.20	-0.12	-0.16%	73.32	73.95	73.14

Metlife Events

Time (UTC)	Country	Event
Wednesday, May 1, 2024
Time (UTC) 20:00	Country US	Event Q1 2024 MetLife Inc Earnings Release Q1 2024 MetLife Inc Earnings Release Forecast - Previous -
Thursday, May 2, 2024
Time (UTC) 13:00	Country US	Event Q1 2024 MetLife Inc Earnings Call Q1 2024 MetLife Inc Earnings Call Forecast - Previous -
Wednesday, June 19, 2024
Time (UTC) 18:30	Country US	Event Metlife Inc Annual Shareholders Meeting Metlife Inc Annual Shareholders Meeting Forecast - Previous -
Wednesday, July 31, 2024
Time (UTC) 10:59	Country US	Event Q2 2024 MetLife Inc Earnings Release Q2 2024 MetLife Inc Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	69898	71080	67842	69750	67981
Other Revenue, Total	5585	5756	5603	5603	5502
Total Operating Expense	66101	62034	60002	62000	60552
Selling/General/Admin. Expenses, Total	7200	7276	7629	8439	8471
Unusual Expense (Income)				130	40
Other Operating Expenses, Total	3651	5504	5169	6431	3957
Operating Income	3797	9046	7840	7750	7429
Interest Income (Expense), Net Non-Operating	-938	-920	-913	-955	-1122
Net Income Before Taxes	2859	8126	6927	6795	6307
Net Income After Taxes	2558	6575	5418	5909	5128
Minority Interest	-19	-21	-11	-10	-5
Net Income Before Extra. Items	2539	6554	5407	5899	5123
Total Extraordinary Items				0	0
Net Income	2539	6554	5407	5899	5123
Total Adjustments to Net Income	-185	-201	-216	-178	-141
Income Available to Common Excl. Extra. Items	2354	6353	5191	5721	4982
Income Available to Common Incl. Extra. Items	2354	6353	5191	5721	4982
Diluted Net Income	2354	6353	5191	5721	4982
Diluted Weighted Average Shares	869.4	869.4	913.2	944.4	1013.9
Diluted EPS Excluding Extraordinary Items	2.70761	7.30734	5.68441	6.05781	4.9137
Dividends per Share - Common Stock Primary Issue	1.98	1.9	1.82	1.74	1.66
Diluted Normalized EPS	2.70761	7.34922	5.68441	6.17752	4.94578
Total Premiums Earned	52031	44628	43883	44077	45720
Net Investment Income	15916	21395	17117	18868	16166
Realized Gains (Losses)	-3634	-699	1239	1202	593
Losses, Benefits, and Adjustments, Total	55877	49417	47057	47462	48363
Amort. Of Policy Acquisition Costs	-627	-163	147	-462	-279

	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022
Total revenue	16623	15388	16316	22270	15474
Other Revenue, Total	1288	1289	1349	1302	1372
Total Operating Expense	15937	14876	14341	21612	14260
Selling/General/Admin. Expenses, Total	1837	1799	1870	1780	1762
Other Operating Expenses, Total	1110	2045	1580	968	-237
Operating Income	686	512	1975	658	1214
Interest Income (Expense), Net Non-Operating	-256	-255	-248	-239	-226
Net Income Before Taxes	430	257	1727	419	988
Net Income After Taxes	408	85	1346	400	915
Minority Interest	-6	-5	-3	-5	-5
Net Income Before Extra. Items	402	80	1343	395	910
Net Income	402	80	1343	395	910
Total Adjustments to Net Income	-32	-66	-29	-64	-29
Income Available to Common Excl. Extra. Items	370	14	1314	331	881
Income Available to Common Incl. Extra. Items	370	14	1314	331	881
Diluted Net Income	370	14	1314	331	881
Diluted Weighted Average Shares	769.6	781.2	1032	800.7	814.5
Diluted EPS Excluding Extraordinary Items	0.48077	0.01792	1.27326	0.41339	1.08165
Dividends per Share - Common Stock Primary Issue	0.52	0.5	0.5	0.5	0.5
Diluted Normalized EPS	0.48077	0.01792	1.27326	0.41339	1.08165
Total Premiums Earned	12299	10228	9986	18277	12171
Net Investment Income	5072	4645	4464	3585	3583
Realized Gains (Losses)	-2036	-774	517	-894	-1652
Losses, Benefits, and Adjustments, Total	13240	11280	11002	19261	12914
Amort. Of Policy Acquisition Costs	-250	-248	-111	-397	-179

Annual
Quarterly

	2022	2021	2020	2019	2018
Cash & Equivalents	20195	20047	19795	16598	15821
Total Assets	663072	759708	795146	740463	687538
Goodwill, Net	9297	9535	10112	9308	9422
Long Term Investments	420156	482605	496586	463054	426512
Note Receivable - Long Term	42	184
Other Long Term Assets, Total		7238	7418
Other Assets, Total	193729	220528	241032	229982	214588
Notes Payable/Short Term Debt	175	341	393	235	268
Other Current Liabilities, Total	387	2160	3685	3064	1546
Total Liabilities	633191	692226	720588	674319	634797
Total Long Term Debt	17805	17089	17756	16616	15976
Long Term Debt	17805	17008	17650	16491	15972
Deferred Income Tax	950	9693	11008	9097	5414
Minority Interest	244	267	259	238	217
Other Liabilities, Total	25933	27877	26794	22525	22964
Total Equity	29881	67482	74558	66144	52741
Preferred Stock - Non Redeemable, Net	0	0	0	0	0
Common Stock	12	12	12	12	12
Additional Paid-In Capital	33616	33511	33812	32680	32474
Retained Earnings (Accumulated Deficit)	40332	41197	36491	33078	28926
Treasury Stock - Common	-21458	-18157	-13829	-12678	-10393
Unrealized Gain (Loss)	-22646	16042	22217	18283	7042
Other Equity, Total	25	-5123	-4145	-5231	-5320
Total Liabilities & Shareholders’ Equity	663072	759708	795146	740463	687538
Total Common Shares Outstanding	779.098	825.54	892.911	915.338	958.614
Property/Plant/Equipment, Total - Net		2210	2614	2788	1400
Property/Plant/Equipment, Total - Gross		2700	2800	2700	2600
Accumulated Depreciation, Total		-1600	-1500	-1400	-1200
Intangibles, Net		1300	1200	900	900
Capital Lease Obligations		81	106	125	4
Total Preferred Shares Outstanding	24.5722	24.5722	25.0722	26.0322	26.0322
Accrued Expenses		1295	1470	1654

	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Cash & Equivalents	14912	15417	18456	20195	22200
Total Assets	652120	677279	674266	663072	650104
Goodwill, Net	9109	9261	9379	9297	9005
Long Term Investments	422529	437903	428147	420156	413864
Note Receivable - Long Term	0	189	0	42	194
Other Long Term Assets, Total					0
Other Assets, Total	185833	194659	198308	193729	183318
Notes Payable/Short Term Debt	161	200	168	175	183
Other Current Liabilities, Total	440	366	910	387	429
Total Liabilities	626462	647018	642072	633191	625028
Total Long Term Debt	18635	17699	17781	17805	17678
Long Term Debt	18635	17699	17781	17805	17678
Deferred Income Tax	128	752	1111	950	172
Minority Interest	237	231	229	244	254
Other Liabilities, Total	34698	34555	25112	25933	27509
Total Equity	25658	30261	32194	29881	25076
Preferred Stock - Non Redeemable, Net	0	0	0	0	0
Common Stock	12	12	12	12	12
Additional Paid-In Capital	33666	33630	33617	33616	33589
Retained Earnings (Accumulated Deficit)	39958	39928	39957	40332	41032
Treasury Stock - Common	-23724	-22923	-22245	-21458	-20862
Unrealized Gain (Loss)	-27169	-17979	-16354	-22646	-23040
Other Equity, Total	2915	-2407	-2793	25	-5655
Total Liabilities & Shareholders’ Equity	652120	677279	674266	663072	650104
Total Common Shares Outstanding	744.366	757.21	769.179	779.098	787.341
Total Preferred Shares Outstanding	24.5722	24.5722	24.5722	24.5722	24.5722

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	2558	6575	5418	5909	5128
Cash From Operating Activities	13204	12596	11639	13786	11738
Cash From Operating Activities	673	694	619	630	628
Non-Cash Items	-688	-2054	944	116	-2251
Cash Taxes Paid	1056	1102	787	1099	1935
Cash Interest Paid	905	914	891	964	1130
Changes in Working Capital	10661	7381	4658	7131	8233
Cash From Investing Activities	-2620	-11187	-18569	-17586	-5634
Other Investing Cash Flow Items, Total	-2620	-11187	-18569	-17586	-5634
Cash From Financing Activities	-10108	-1375	10729	4568	-2801
Financing Cash Flow Items	4853	4019	8366	6246	4465
Total Cash Dividends Paid	-1783	-1842	-1859	-1821	-1819
Issuance (Retirement) of Stock, Net	-3326	-4803	-193	-2285	-2718
Issuance (Retirement) of Debt, Net	-9852	1251	4415	2428	-2729
Foreign Exchange Effects	-397	-478	163	9	-183
Net Change in Cash	79	-444	3962	777	3120

	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Cash From Operating Activities	2026	13204	10670	6392	2040
Cash Taxes Paid	171	1056	612	577	95
Cash Interest Paid	183	905	591	435	150
Changes in Working Capital	2026	13204	10670	6392	2040
Cash From Investing Activities	-1504	-2620	-2423	1689	-426
Other Investing Cash Flow Items, Total	-1504	-2620	-2423	1689	-426
Cash From Financing Activities	-2295	-10108	-5407	-7182	1865
Financing Cash Flow Items	30	4853	4387	3622	4618
Total Cash Dividends Paid	-455	-1783	-1361	-897	-460
Issuance (Retirement) of Stock, Net	-780	-3326	-2730	-2056	-940
Issuance (Retirement) of Debt, Net	-1090	-9852	-5703	-7851	-1353
Foreign Exchange Effects	34	-397	-756	-467	-84
Net Change in Cash	-1739	79	2084	432	3395

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Metlife Company profile

MetLife (MET) is an American provider of financial services and insurance. Founded in 1868, the company serves individual clients providing auto, dental, disability, home, life, vision, accident & health insurance and annuities. MetLife also offers group insurance such as employee benefits and broker supplemental compensation programmes. MetLife operates in around 50 countries with a strong position in the USA, Japan, Latin America, Asia, Europe and the Middle East. The company has approximately 100 million customers worldwide and is headquartered in New York, USA. It is traded on the New York Stock Exchange (NYSE). Find the recent MetLife share price at Capital.com.

Industry:

Life & Health Insurance (NEC)

200 Park Avenue
NEW YORK
NEW YORK 10166
US

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024